Article
Amyotrophic lateral sclerosis models derived from human embryonic stem cells with different superoxide dismutase 1 mutations exhibit differential drug responses.
Stem cell research - 1 Nov 2015
Isobe Takehisa, Tooi Norie, Nakatsuji Norio, Aiba Kazuhiro
Abstract excerpt
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative motor neuron (MN) disease. The gene encoding superoxide dismutase 1 (SOD1) is a causative element of familial ALS. Animal ALS models involving SOD1 gene mutations are widely used to study the underlying mechanisms of disease and facilitate drug discovery. Unfortunately, most drug candidates have failed in clinical trials, potentially due to species...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
